RO
Rossari Biotech Limited
ROSSARI.NS · NSE
₹429.75 -0.27% (-₹1.15)
1M -6.02%
Market Cap ₹24.1B
P/E Ratio 15.98x
Div. Yield 0.11%
ROE 11.66%
Bulios Fair Price
₹339.23
21.1% downside
Current Price
₹429.75
Undervalued Fair Value Overvalued
According to Bulios Fair Price, ROSSARI.NS is currently overvalued relative to its market price. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Analysis
An AI report on the business, its finances, valuation, sentiment, news and risks - written in a few minutes.
Piotroski F-Score Weak
2/9Valuation
69 /100
Cheap EV/EBITDA 7.44x
P/S 0.94x
P/B 1.81x
Growth
89 /100
Growing Rev. growth 13.11%
Book val. growth 13.37%
EPS growth 11.59%
Profitability
43 /100
Moderate Net margin 5.91%
Op. margin 8.30%
FCF margin 6.54%
Quality
73 /100
Excellent ROE 11.66%
ROA N/A
Asset turnover N/A
Debt
98 /100
Low Int. coverage 7.01x
Net debt/EBITDA 0.00x
Debt/Equity 0.00x
Stability
78 /100
Stable Rev. volatility 2.36%
EPS volatility 9.06%
Profitable years 6
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about ROSSARI.NS
Online
Sector
Basic Materials
Industry
Chemicals - Specialty
CEO
Sunil Chari
Employees
585
Headquarters
Mumbai
Upcoming events
19 OCT
Earnings
Upcoming earnings report